2025 colorectal screening: Over 8,500 tests, hundreds referred for follow-up

In 2025, over 8,500 people benefited from colorectal screening services provided through a prevention program funded by public health resources, according to the National Health Insurance Company.
The testing was conducted among asymptomatic individuals aged 50 to 55 years in the municipalities of Chișinău (specifically in the Botanica, Râșcani, and Centru sectors) and Bălți, as well as in the districts of Cahul, Călărași, Ungheni, Cantemir, Cimișlia, and Edineț.
Over 460 positive results
According to the National Health Insurance Company (CNAM), more than 460 people received positive screening results, with 311 scheduled for colonoscopy. These investigations were carried out in public institutions designated by the Ministry of Health of the Republic of Moldova, including the Oncology Institute and several municipal and district hospitals.
In total, 257 people underwent colonoscopy last year, and approximately one in five individuals examined was diagnosed with precancerous conditions or cancer. This early detection allowed for timely initiation of treatment.
"Early detection significantly increases the chances of treatment and survival. Colorectal screening remains one of the most effective preventive measures in oncology," states the National Health Insurance Company.
What is the iFOB Test?
The screening utilized the immunochemical fecal occult blood test (iFOB), a non-invasive method designed to detect microscopic bleeding that may indicate the presence of precancerous lesions or colorectal cancer. Individuals who received a positive result were subsequently referred for colonoscopy to confirm the diagnosis.
The expenses for colorectal screening in 2025 were funded by the CNAM's prevention measures fund, totaling over 560 thousand lei.
For 2026, 4.3 million lei has been approved from the same fund to expand the program. According to the authorities, these investments aim to increase the rate of early colorectal cancer detection, reduce mortality, and improve the quality of life for the population.